Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Atlantic begins rolling NDA submission for pouchitis candidate alicaforsen

May 12, 2017 3:56 AM UTC

Atlantic Healthcare plc (Saffron Walden, U.K.) began submission of a rolling NDA to FDA for alicaforsen (AP 1007) to treat pouchitis. The antisense inhibitor of intercellular adhesion molecule-1 (ICAM-1; CD54) is in a Phase III trial in the indication...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article